Episode #2 explores the EMA and HMA 2024 workshop on AI in medicine, focusing on pharmacovigilance (PV).
This event brought together experts to discuss the safe and responsible integration of AI in monitoring and ensuring drug safety.
Key topics included:
- AI in ICSR Management
- Regulatory Perspectives: Insights into the EU AI Act and the EMA's AI Reflection Paper, outlining the legal and regulatory frameworks guiding AI applications in PV.
- Collaborative Initiatives: Updates on the FDA/EMA cluster on AI in Pharmacovigilance
The importance of stakeholder collaboration to ensure AI technologies are harnessed effectively to protect public health.
Link to YouTube: https://youtu.be/TpVrxWhoaqc?si=bExf93lw8vgHu2ns